akhatri

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 September 2026. Generic drug name (dm+d descriptor) Brand and/or manufacturer Pack Size Special container Ethinylestradiol 20microgram / Desogestrel 150microgram tablets Bimizza® 150microgram/20microgram tablets (Morningside Healthcare Ltd) 63 tablet [...]

The post 5 products re-classified as special containers from September 2026 appeared first on Community Pharmacy England.

The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 September 2026. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...]

The post Drug Tariff Watch – September 2026 appeared first on Community Pharmacy England.

The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 September 2026. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...]

The post Drug Tariff Watch – September 2026 appeared first on Community Pharmacy England.

As part of our Funding & Reimbursement Shorts series, Community Pharmacy England’s in-house Drug Tariff experts have created a new video discussing the structure of the Drug Tariff. In this video, we provide guidance on the different parts of Part VIII of the Drug Tariff, with a particular focus on Part VIIIA. In this video, Mitesh [...]

The post Funding & Reimbursement Shorts: Part VIII of the Drug Tariff appeared first on Community Pharmacy England.

Following the introduction of Category H in March 2026, the Department of Health and Social Care (DHSC) has announced that the following 8 products will move from Category C to Category H, effective from September 2026: Alfuzosin 10mg modified-release tablets Diclofenac 100mg suppositories Felodipine 10mg modified-release tablets Felodipine 2.5mg modified-release tablets Felodipine 5mg modified-release tablets [...]

The post Advance notice of 8 products moving to Category H in September 2026 appeared first on Community Pharmacy England.